73 related articles for article (PubMed ID: 23013419)
1. CD8+ Sézary syndrome with interleukin-22 production modulated by bacterial sepsis.
Shimauchi T; Sasada K; Kito Y; Mori T; Hata M; Fujiyama T; Ito T; Hirakawa S; Tokura Y
Br J Dermatol; 2013 Apr; 168(4):881-3. PubMed ID: 23013419
[No Abstract] [Full Text] [Related]
2. Cutaneous colonization with staphylococci influences the disease activity of Sézary syndrome: a potential role for bacterial superantigens.
Tokura Y; Yagi H; Ohshima A; Kurokawa S; Wakita H; Yokote R; Shirahama S; Furukawa F; Takigawa M
Br J Dermatol; 1995 Jul; 133(1):6-12. PubMed ID: 7669641
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a malignant T-cell line established from a rare case of CD8+ CD56+ Sézary syndrome.
Shimauchi T; Yagi H; Sasada K; Kito Y; Ito T; Hirakawa S; Tokura Y
Br J Dermatol; 2013 Apr; 168(4):885-7. PubMed ID: 23013154
[No Abstract] [Full Text] [Related]
4. Absence of T(H)2 cytokine messenger RNA expression in CD30-negative primary cutaneous large T-cell lymphomas.
Vermeer MH; Tensen CP; van der Stoop PM; van Oostveen HW; Lund M; Scheper RJ; Willemze R
Arch Dermatol; 2001 Jul; 137(7):901-5. PubMed ID: 11453809
[TBL] [Abstract][Full Text] [Related]
5. CD8(+) T lymphocytes reactive against Epstein-Barr virus antigens in skin lesions of a patient with Sézary syndrome.
Knol AC; Guilloux Y; Quéreux G; Marques-Briand S; Pandolfino MC; Khammari A; Dreno B
J Am Acad Dermatol; 2005 Nov; 53(5):897-900. PubMed ID: 16243153
[TBL] [Abstract][Full Text] [Related]
6. The "Duvic regimen" for erythrodermic flares secondary to Staphylococcus aureus in mycosis fungoides and Sézary syndrome.
Lewis DJ; Holder BB; Duvic M
Int J Dermatol; 2018 Jan; 57(1):123-124. PubMed ID: 29152728
[No Abstract] [Full Text] [Related]
7. [Sézary syndrome with two lymphocyte subpopulations expressing either CD4+/CD8- or CD4-/CD8+].
Kodama K; Kataoka Y; Tamura T; Arai J; Matsuo T
Rinsho Ketsueki; 1997 Nov; 38(11):1238-41. PubMed ID: 9423345
[TBL] [Abstract][Full Text] [Related]
8. Sézary T-cell-activating factor induces functional interleukin 2 receptors on T-cells derived from patients with Sézary syndrome.
Abrams JT; Ghosh SK; DeFreitas E
Cancer Res; 1993 Nov; 53(22):5501-6. PubMed ID: 8221690
[TBL] [Abstract][Full Text] [Related]
9. Artesunate in combination with oxacillin protect sepsis model mice challenged with lethal live methicillin-resistant Staphylococcus aureus (MRSA) via its inhibition on proinflammatory cytokines release and enhancement on antibacterial activity of oxacillin.
Jiang W; Li B; Zheng X; Liu X; Cen Y; Li J; Pan X; Cao H; Zheng J; Zhou H
Int Immunopharmacol; 2011 Aug; 11(8):1065-73. PubMed ID: 21396483
[TBL] [Abstract][Full Text] [Related]
10. [Cutaneous CD8 lymphocyte infiltration syndrome associated with human immunodeficiency virus infection].
Bachelez H
Ann Dermatol Venereol; 1999 Oct; 126(10):673-4. PubMed ID: 10604002
[No Abstract] [Full Text] [Related]
11. A novel mouse model for Sézary syndrome using xenotransplantation of Sézary cells into immunodeficient RAG2(-/-) γc(-/-) mice.
van der Fits L; Rebel HG; Out-Luiting JJ; Pouw SM; Smit F; Vermeer KG; van Zijl L; Tensen CP; Weijer K; Vermeer MH
Exp Dermatol; 2012 Sep; 21(9):706-9. PubMed ID: 22897578
[TBL] [Abstract][Full Text] [Related]
12. [Sézary syndrome. Clinical, immunological and proliferative kinetics].
Marosi L; Hofer F; Schwarzmeier J; Konrad K; Knapp W; Radaskiewicz T
Acta Med Austriaca; 1979; 6(5):237-40. PubMed ID: 318012
[TBL] [Abstract][Full Text] [Related]
13. Association of change in clinical status and change in the percentage of the CD4+CD26- lymphocyte population in patients with Sézary syndrome.
Introcaso CE; Hess SD; Kamoun M; Ubriani R; Gelfand JM; Rook AH
J Am Acad Dermatol; 2005 Sep; 53(3):428-34. PubMed ID: 16112348
[TBL] [Abstract][Full Text] [Related]
14. High clinical response rate of Sezary syndrome to immunomodulatory therapies: prognostic markers of response.
Raphael BA; Shin DB; Suchin KR; Morrissey KA; Vittorio CC; Kim EJ; Gardner JM; Evans KG; Introcaso CE; Samimi SS; Gelfand JM; Rook AH
Arch Dermatol; 2011 Dec; 147(12):1410-5. PubMed ID: 21844430
[TBL] [Abstract][Full Text] [Related]
15. Serum levels of CC chemokine receptor 4 and CXC chemokine receptor 3 ligands in CD8(+) Sézary syndrome.
Uchi H; Hayashida S; Takahara M; Moroi Y; Furue M
Acta Derm Venereol; 2012 May; 92(3):280-1. PubMed ID: 22293715
[No Abstract] [Full Text] [Related]
16. Sézary syndrome: relative increase in T helper lymphocytes demonstrated by monoclonal antibodies.
Thivolet J; Fulton R; Souteyrand P; Gaucherand M; Claudy A
Acta Derm Venereol; 1982; 62(4):337-40. PubMed ID: 6183869
[No Abstract] [Full Text] [Related]
17. [Comparative analysis of the expression of cell adhesion molecules in cutaneous T-cell lymphomas (mycosis fungoides/Sézary syndrome) and inflammatory skin diseases].
López-Lerma I; Estrach MT
Actas Dermosifiliogr; 2010 Dec; 101(10):866-77. PubMed ID: 21159263
[TBL] [Abstract][Full Text] [Related]
18. Increased interleukin 5 production in eosinophilic Sézary syndrome: regulation by interferon alfa and interleukin 12.
Suchin KR; Cassin M; Gottleib SL; Sood S; Cucchiara AJ; Vonderheid EC; Rook AH
J Am Acad Dermatol; 2001 Jan; 44(1):28-32. PubMed ID: 11148473
[TBL] [Abstract][Full Text] [Related]
19. Abnormal cytokine expression in Sézary and adult T-cell leukemia cells correlates with the functional diversity between these T-cell malignancies.
Tendler CL; Burton JD; Jaffe J; Danielpour D; Charley M; McCoy JP; Pittelkow MR; Waldmann TA
Cancer Res; 1994 Aug; 54(16):4430-5. PubMed ID: 7913876
[TBL] [Abstract][Full Text] [Related]
20. Recovery from Sézary syndrome following Mycobacterium avium spondylitis.
Yamada A; Yamasaki O; Asagoe K; Tsuji K; Hamada T; Ota Y; Iwatsuki K
Br J Dermatol; 2007 Dec; 157(6):1270-1. PubMed ID: 17916220
[No Abstract] [Full Text] [Related]
[Next] [New Search]
